Health · 1 sources covering this

How a targeted drug kept one patient alive 15 years — but failed to save her friends

A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality of life for survivors — not so much.”

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
How a targeted drug kept one patient alive 15 years — but failed to save her friends
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality of life for survivors — not so much.”
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/730bfa114f8039e2a190725daa291dd5b1cdbef5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="How a targeted drug kept one patient alive 15 years — but failed to save her friends"></iframe>

How a targeted drug kept one patient alive 15 years — but failed to save her friends

How 1 sources are covering this

How a targeted drug kept one patient alive 15 years — but failed to save her friends

More from Health

STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

What if you gave yourself a day to cancel all the plans you dread?

Shopping for an ACA Plan This Year? Here’s What You Need To Know

GOP Congressman in California Swing-District Race Defends Vote for Medicaid Cuts

Reader

Trust & legal

Across the network